ArticleJournal of nanobiotechnology2026
An integrated green control strategy for plant viral co-infections: from multivalent vaccine construction to synergistically modified nanodelivery systems.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Plant viral co-infections pose a significant threat to global agricultural productivity. In this study, a novel multivalent attenuated vaccine (CMV-R2TP) was developed using the cucumber mosaic virus (CMV) as a backbone, together with a ROS-responsive vaccine nanodelivery system (pCMV-R2TP@PTP-TAT), offering a comprehensive and environmentally friendly strategy for managing plant viruses. Through the modification of the CMV 2b protein, a stable base vector (pR2-2bIII) capable of accommodating up to 400 bp foreign fragments was constructed. The resulting CMV-R2TP vaccine demonstrated protective efficacy ranging from 41.28% to 53.78% against co-infections caused by CMV, TMV, and PVY. To address the constraints of conventional Agrobacterium-mediated delivery, a novel nanodelivery platform, pCMV-R2TP@PTP-TAT, was synthesized through synergistic modification of PLGA with PEI, TK, and TAT. This system demonstrated excellent physicochemical characteristics, achieving 87.1% ROS-responsive release within just 4 h. It was also found to be capable of efficiently delivering nucleic acids into plant cells, resulting in gene expression levels comparable to those achieved by Agrobacterium transformation within 120 h. Notably, the pCMV-R2TP@PTP-TAT system showed exceptional biocompatibility, neither harming plant tissues nor inducing oxidative stress responses. Overall, a comprehensive technical platform was established, integrating multivalent vaccine design, nanodelivery optimization, and safety assessment. This system combines measurable protective efficacy with favorable environmental safety, offering a scalable approach for sustainable management of plant viral diseases and paving the way for novel applications in agricultural nanobiotechnology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.